Hologic (NSDQ:HOLX) announced today that it entered into a definitive agreement to acquire diagnostic developer Mobidiag Oy for $795 million. Finland/France–based Mobidiag develops and markets PCR-based tests for acute care conditions, including gastrointestinal and respiratory infections, antimicrobial resistance management and healthcare-associated infections. Mobidiag’s Amplidiag and Novodiag platforms are automated instruments that deliver rapid turnaround times […]
Mergers & Acquisitions
Dräger acquires majority share of Stimit and its tech to help people breathe
Dräger recently announced that it has acquired a majority stake in Swiss medtech startup Stimit and its noninvasive tech to stimulate intensive care patients’ respiratory muscles. The financial terms of the deal were not disclosed in the April 1 announcement. Stimit will work with Dräger in the following months to further develop the product and […]
Better Therapeutics to go public via $113M merger with SPAC
Better Therapeutics announced today that, through a $113 million merger with Mountain Crest Acquisition Corp II, it will go public. Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), will acquire Better Therapeutics in a deal expected to be completed in the summer of this year, with the company continuing to operate as Better Therapeutics […]
LumiraDx to start trading on Nasdaq through $5B SPAC deal
CA Healthcare Acquisition Corp.— a special purpose acquisition company — announced today that it entered a merger agreement with LumiraDx that will take the company public. London-based LumiraDx, a point-of-care diagnostics developer, will merge with CAHC with the combination reflecting a value of $5 billion for Lumira’s existing equity, according to a news release. Since […]
Erbe Elektromedizin to acquire Maxer Endoscopy
Erbe Elektromedizin announced today that it is set to acquire Maxer Endoscopy for an undisclosed amount. Teubingen, Germany–based Erbe Elektromedizin develops, manufactures and distributes surgical instruments and devices in almost all specialist areas. Combined with other Erbe technologies, the surgical instruments are based on electrosurgery. Tuttlingen, Germany–based Maxer specializes in a wide range of endoscopic […]
Second Sight, Pixium Vision merger plans are over
Second Sight Medical notified Pixium that it decided to unilaterally terminate a memorandum of understanding (MOU) ahead of a planned merger. In a news release, Pixium said the $27.9 million private placement recently announced and closed by Second Sight was “not only explicitly prohibited under the terms of the [MOU] entered into by the companies […]
MedTech 100 roundup: Heading back to previous heights?
Although March brought on tough times for top stocks in the medtech industry, April is already showing signs of a rebound. The year’s strong start, during which MassDevice‘s MedTech 100 index notched an all-time best of 110.96 points (Feb. 15) came to an end later that month and carried over into March, with the index hitting its lowest […]
Illumina postpones $8B Grail deal amid FTC challenge
Illumina (NSDQ:ILMN) has delayed its proposed $8 billion acquisition of Grail amid a FTC challenge. The companies have agreed to postpone the planned purchase until after Sept. 20 while the FTC challenges the deal, according to a temporary restraining order issued out of U.S. District Court in the District of Columbia. News of Illumina’s agreement […]
Medbio consolidates two acquisitions
Contract manufacturer Medbio (Grand Rapids, Mich.) announced today that it is consolidating and rebranding its recent acquisitions, Polymer Conversions and AIM Plastics. Medbio acquired Polymer Conversions in September 2020 and bought AIM Plastics in 2019. Polymer Conversions is a medical device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly. AIM adds scale to Medbio’s business, which […]
Illumina vows to pursue Grail purchase despite FTC challenge
Illumina (NSDQ:ILMN) announced today that it disagrees with and will oppose the FTC’s challenge to its acquisition of Grail. San Diego-based Illumina announced in September that it entered into an agreement to acquire the cancer detection startup that spun out from the company four years ago for cash and stock consideration of $8 billion. founded […]
Merck spinoff Organon to acquire Alydia Health for up to $240M
Merck (NYSE: MRK) announced today that it entered into an agreement for its spinoff Organon to acquire Alydia Health for up to $240 million. Alydia Health develops treatments focusing on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding, according to a news release. The company develops the Jada […]
